Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

C-terminal degradation of PYY peptides in plasma abolishes effects on satiety and beta-cell function
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Biochemical Pharmacology (2018) Vol. 158, pp. 95-102
Open Access | Times Cited: 22

Showing 22 citing articles:

Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies
Manuel Lisardo Sánchez, Francisco D. Rodríguez, Rafael Coveñas
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9962-9962
Open Access | Times Cited: 23
The Mechanism of the Gut-Brain Axis in Regulating Food Intake
Shouren Li, Mengqi Liu, Shixi Cao, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3728-3728
Open Access | Times Cited: 21
The effect of fatty diacid acylation of human PYY3-36 on Y2 receptor potency and half-life in minipigs
Søren Østergaard, Johan F. Paulsson, Jacob Kofoed, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Evolution of peptide YY analogs for the management of type 2 diabetes and obesity
Wang Chen, Gong Binbin, Lidan Sun, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106808-106808
Closed Access | Times Cited: 14
Established and emerging roles peptide YY (PYY) and exploitation in obesity–diabetes
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Current Opinion in Endocrinology Diabetes and Obesity (2020) Vol. 28, Iss. 2, pp. 253-261
Open Access | Times Cited: 39
Macroalgal protein hydrolysates from Palmaria palmata influence the ‘incretin effect’ in vitro via DPP-4 inhibition and upregulation of insulin, GLP-1 and GIP secretion
Chris M. McLaughlin, Pádraigín A. Harnedy‐Rothwell, Ryan A. Lafferty, et al.
European Journal of Nutrition (2021) Vol. 60, Iss. 8, pp. 4439-4452
Open Access | Times Cited: 22
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
Ryan A. Lafferty, Neil Tanday, R. Charlotte Moffett, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 21
Effects of 2 Novel PYY(1-36) Analogues, (P3L31P34)PYY(1-36) and PYY(1-36)(Lys12PAL), on Pancreatic Beta-Cell Function, Growth, and Survival
Ryan A. Lafferty, Victor A. Gault, Peter R. Flatt, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2019) Vol. 12
Open Access | Times Cited: 25
Characterisation of Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonists in Rodent Pancreatic Beta Cells and Mice
R W Perry, S.R. Craig, MT Ng, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2019) Vol. 12
Open Access | Times Cited: 19
Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists
Neil Tanday, Ryan A. Lafferty, Peter R. Flatt, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 12, pp. 2353-2363
Open Access | Times Cited: 11
Effects of an enzymatically stable C-terminal hexapseudopeptide fragment peptide of xenin-25, ψ-xenin-6, on pancreatic islet function and metabolism
Stephen L. Craig, Victor A. Gault, Stephen McClean, et al.
Molecular and Cellular Endocrinology (2019) Vol. 496, pp. 110523-110523
Open Access | Times Cited: 14
Development and characterisation of a peptidergic N-and C-terminally stabilised mammalian NPY1R agonist which protects against diabetes induction
Ryan A. Lafferty, Neil Tanday, Peter R. Flatt, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2020) Vol. 1864, Iss. 5, pp. 129543-129543
Open Access | Times Cited: 14
NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management?
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Peptides (2024) Vol. 179, pp. 171256-171256
Open Access | Times Cited: 1
Generation and characterisation of C-terminally stabilised PYY molecules with potential in vivo NPYR2 activity
Ryan A. Lafferty, Neil Tanday, Peter R. Flatt, et al.
Metabolism (2020) Vol. 111, pp. 154339-154339
Open Access | Times Cited: 9
Engineering a potent and long-acting GLP-1/Y2 receptor dual agonist as a multi-agonist therapy for diabetes and obesity
Jing Xu, Shuang Wang, Han Wu, et al.
Peptides (2023) Vol. 169, pp. 171073-171073
Closed Access | Times Cited: 3
Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction
Elias Haj‐Yehia, R. Mertens, Florian Kahles, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3952-3952
Open Access | Times Cited: 8
Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice
Nathalie Esser, Christine R. Schmidt, Breanne M. Barrow, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 5
Peptides originally derived from Chilobrachys jingzhao tarantula venom possess beneficial effects on pancreatic beta cell health and function
Aimee Coulter‐Parkhill, Victor A. Gault, Stephen McClean, et al.
European Journal of Pharmacology (2023) Vol. 954, pp. 175855-175855
Open Access | Times Cited: 2
Pancreatic Polypeptide but Not Other Members of the Neuropeptide Y Family Shows a Moderate Association With Perceived Anxiety in Obese Men
Selina Johanna Schaper, Tobias Hofmann, Ellen Wölk, et al.
Frontiers in Human Neuroscience (2020) Vol. 14
Open Access | Times Cited: 4
Tryptophan regulates food intake in growing pigs by modulating hypothalamic AMPK-mTOR signaling pathway
Juexin Fan, Yuezhou Yao, Leli Wang, et al.
British Journal Of Nutrition (2024), pp. 1-24
Open Access
Pharmacology of Gut Hormone Mimetics for Obesity and Diabetes
Ryan A. Lafferty, Finbarr O’Harte, Nigel Irwin, et al.
Elsevier eBooks (2021), pp. 301-343
Closed Access | Times Cited: 1
Utilising the therapeutic potential of xenin and related molecules for diabetes and obesity
Sarah Craig
(2020)
Closed Access
Page 1

Scroll to top